0
No hay productos en el carro de la compra
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > LGR5

LGR5

Brief Information

Name:Leucine-rich repeat-containing G-protein coupled receptor 5
Target Synonym:FEX,G Protein-Coupled Receptor 49,GRP49,HG38,G-protein coupled receptor HG38,GPR49,GPR67,G-protein coupled receptor 49,Leucine-rich repeat-containing G-protein coupled receptor 5,LGR5,Leucine Rich Repeat Containing G Protein-Coupled Receptor 5,G-Protein Coupled Receptor 67,Orphan G Protein-Coupled Receptor HG38
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
LG5-H5253 Human Human LGR5 / GPR49 protein, Fc Tag
LG5-H5253-structure
LG5-H5253-sds
LG5-C52H7 Cynomolgus Cynomolgus LGR5 / GPR49 protein, His Tag
LG5-C52H7-structure
LG5-C52H7-sds
LG5-H52H3 Human Human LGR5 / GPR49 protein, His Tag
LG5-H52H3-structure
LG5-H52H3-sds
ACRO Quality

Part of Bioactivity data

LG5-H52H3-SPR
 LGR5 SPR

Human R-Spondin 3 (22-146), His Tag (Cat. No. RS6-H5222) with immobilized on CM5 Chip can bind Human LGR5, His Tag (Cat. No. LG5-H52H3) with an affinity constant of 18.6 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

LG5-C52H7-ELISA
 LGR5 ELISA

Immobilized Cynomolgus LGR5, His Tag (Cat. No. LG5-C52H7) at 5 μg/mL (100 μL/well) can bind Human R-Spondin 1 (21-146), Fc Tag (Cat. No. RS1-H5269) with a linear range of 0.2-5 ng/mL (QC tested).

Synonym Name

LGR5, GPR49, GPR67, G-protein coupled receptor 49, G-protein coupled receptor 67, G-protein coupled receptor HG38, Leucine-rich repeat-containing G-protein coupled receptor 5

Background

LGR5 (also known as GPR49) is a seven-transmembrane protein of the class A Rhodopsin-like family of GPCRs. LGR5 and LGR4 bind the R-spondins with high affinity and mediate the potentiation of Wnt/β-catenin signaling by enhancing Wnt-induced LRP6 phosphorylation. The LGR5/RSPO complex could promote Wnt signalling via the neutralization of two transmembrane E3 ligases, RNF43 and ZNRF3.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Petosemtamab MCLA-158 Phase 2 Clinical Merus Nv Solid tumours; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms; Neoplasm Metastasis Details
CNA-3103 CNA-3103 Phase 2 Clinical Carina Biotech Pty Ltd Colorectal Neoplasms Details
Petosemtamab MCLA-158 Phase 2 Clinical Merus Nv Solid tumours; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms; Neoplasm Metastasis Details
CNA-3103 CNA-3103 Phase 2 Clinical Carina Biotech Pty Ltd Colorectal Neoplasms Details

This web search service is supported by Google Inc.

totop
Email
Correo electrónico
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Dejar un mensaje